HMGB1 Level in Cerebrospinal Fluid as a Marker of Treatment Outcome in Patients with Acute Hydrocephalus Following Aneurysmal Subarachnoid Hemorrhage

Journal of Stroke and Cerebrovascular Diseases

Volumn 24, Issue 8, 2015, Pages 1897-1904

  Sokół, Bartosz ^a   Woźniak, Anna ^b   Jankowski, Roman ^a   Jurga, Stefan ^b   Wąsik, Norbert ^a   Shahid, Hinna ^a   Grzes̈kowiak, Bartosz ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b ADAM MICKIEWICZ UNIVERSITY   (Poland)

Author keywords

biomarkers; cerebrospinal fluid; high mobility group box 1; HMGB1; proteomic; subarachnoid hemorrhage

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN; HIGH MOBILITY GROUP B1 PROTEIN;

ADULT; ANASTOMOSIS; ANEURYSM RUPTURE; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; ENDOVASCULAR COILING; FEMALE; GLASGOW OUTCOME SCALE; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HUNT AND HESS SCALE; HYDROCEPHALUS; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEOMICS; RATING SCALE; SUBARACHNOID HEMORRHAGE; SURGICAL TECHNIQUE; SURVIVOR; TREATMENT OUTCOME; WORLD FEDERATION OF NEUROLOGICAL SURGEON SCALE; AGED; ARTIFICIAL EMBOLIZATION; BLOOD CELL COUNT; COMPLICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GLASGOW COMA SCALE; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PROCEDURES; STATISTICS;

AGED; BLOOD CELL COUNT; C-REACTIVE PROTEIN; EMBOLIZATION, THERAPEUTIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGEN; GLASGOW COMA SCALE; HMGB1 PROTEIN; HUMANS; HYDROCEPHALUS; MALE; MIDDLE AGED; STATISTICS AS TOPIC; STATISTICS, NONPARAMETRIC; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 84938743663     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2015.05.002     Document Type: Article

References (28)

1. F.A. Sehba, J. Hou, R.M. Pluta, and J.H. Zhang The importance of early brain injury after subarachnoid hemorrhage Prog Neurobiol 97 2012 14 37
2. M.D. Vergouwen, M. Vermeulen, J. van Gijn, and et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group Stroke 41 2010 2391 2395
3. G. Cossu, M. Messerer, M. Oddo, and et al. To look beyond vasospasm in aneurysmal subarachnoid haemorrhage Biomed Res Int 2014 2014 628597
4. F.A. Sehba, R.M. Pluta, and J.H. Zhang Metamorphosis of subarachnoid hemorrhage research: from delayed vasospasm to early brain injury Mol Neurobiol 43 2011 27 40
5. M.D. King, M.D. Laird, S.S. Ramesh, and et al. Elucidating novel mechanisms of brain injury following subarachnoid hemorrhage: an emerging role for neuroproteomics Neurosurg Focus 28 2010 E10
6. A. Guldbrandsen, H. Vethe, Y. Farag, and et al. In-depth characterization of the cerebrospinal fluid proteome displayed through the CSF Proteome Resource (CSF-PR) Mol Cell Proteomics 13 2014 3152 3163
7. U. Andersson, and K.J. Tracey HMGB1 is a therapeutic target for sterile inflammation and infection Annu Rev Immunol 29 2011 139 162
8. J. Qiu, J. Xu, Y. Zheng, and et al. High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia Stroke 41 2010 2077 2082
9. T. Nakahara, R. Tsuruta, T. Kaneko, and et al. High-mobility group box 1 protein in CSF of patients with subarachnoid hemorrhage Neurocrit Care 11 2009 362 368
10. X.D. Zhu, J.S. Chen, F. Zhou, and et al. Relationship between plasma high mobility group box-1 protein levels and clinical outcomes of aneurysmal subarachnoid hemorrhage J Neuroinflammation 9 2012 194
11. S. Dupont, and A.A. Rabinstein Extent of acute hydrocephalus after subarachnoid hemorrhage as a risk factor for poor functional outcome Neurol Res 35 2013 107 110
12. P.N. Varelas, K.L. Rickert, J. Cusick, and et al. Intraventricular hemorrhage after aneurysmal subarachnoid hemorrhage: pilot study of treatment with intraventricular tissue plasminogen activator Neurosurgery 56 2005 205 213 discussion 205-213
13. M. Salary, M.R. Quigley, and J.E. Wilberger Relation among aneurysm size, amount of subarachnoid blood, and clinical outcome J Neurosurg 107 2007 13 17
14. A.J. Rosengart, K.E. Schultheiss, J. Tolentino, and et al. Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage Stroke 38 2007 2315 2321
15. R.M. Starke, R.J. Komotar, M.L. Otten, and et al. Predicting long-term outcome in poor grade aneurysmal subarachnoid haemorrhage patients utilising the Glasgow Coma Scale J Clin Neurosci 16 2009 26 31
16. D.M. Greer, S.E. Funk, N.L. Reaven, and et al. Impact of fever on outcome in patients with stroke and neurologic injury: a comprehensive meta-analysis Stroke 39 2008 3029 3035
17. E.D. Bertolini, E.G. Figueiredo, and M.J. Teixeira Serum C-reactive protein levels predict neurological outcome after aneurysmal subarachnoid hemorrhage Arq Neuropsiquiatr 70 2011 202 205
18. F. Maiuri, B. Gallicchio, P. Donati, and et al. The blood leukocyte count and its prognostic significance in subarachnoid hemorrhage J Neurosurg Sci 31 1987 45 48
19. P. Nina, G. Schisano, F. Chiappetta, and et al. A study of blood coagulation and fibrinolytic system in spontaneous outcome Surg Neurol 3019 2001 197 203
20. A.M. Naidech, J. Drescher, M.L. Ault, and et al. Higher hemoglobin is associated with less cerebral infarction, poor outcome, and death after subarachnoid hemorrhage Neurosurgery 59 2006 775 779 discussion 779-780
21. A.H. Kramer, M. Hehir, B. Nathan, and et al. A comparison of 3 radiographic scales for the prediction of delayed ischemia and prognosis following subarachnoid hemorrhage J Neurosurg 109 2008 199 207
22. Q. Sun, W. Wu, Y.C. Hu, and et al. Early release of high-mobility group box 1 (HMGB1) from neurons in experimental subarachnoid hemorrhage in vivo and in vitro J Neuroinflammation 11 2014 106
23. K. Hayakawa, J. Qiu, and E.H. Lo Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke Ann N Y Acad Sci 1207 2010 50 57
24. G. Faraco, S. Fossati, M.E. Bianchi, and et al. High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo J Neurochem 103 2007 590 603
25. Q. Yang, J.Z. Wang, J.C. Li, and et al. High-mobility group protein box-1 and its relevance to cerebral ischemia J Cereb blood flow Metab 30 2010 243 254
26. J.A. Ellis, B.E. Youngerman, R.T. Higashida, and et al. Endovascular treatment strategies for acute ischemic stroke Int J Stroke 6 2011 511 522
27. W.C. You, C.X. Wang, Y.X. Pan, and et al. Activation of nuclear factor-κB in the brain after experimental subarachnoid hemorrhage and its potential role in delayed brain injury PLoS One 8 2013 e60290
28. X. Xie, X. Wu, J. Cui, and et al. Increase ICAM-1 and LFA-1 expression by cerebrospinal fluid of subarachnoid hemorrhage patients: involvement of TNF-α Brain Res 1512 2013 89 96